Developing TCR-T cell therapy against viral-related cancers and studying HBV-host-immunity.
Our laboratory focuses on understanding how HBV infection evades or triggers the host-immunity that causes viral control and/or liver inflammation.
Explore Our Research
From groundbreaking TCR-T cell therapy to innovative human nasal T cell research, our team is dedicated to advancing knowledge in cellular adaptive immunology. Dive into our projects to learn more about our efforts to understand the intricacies of T cell function and harness their potential for therapeutic applications.
Discover Our Publications
Explore our articles, papers, and contributions to scientific literature. Whether our work sparks your curiosity or resonates with your research interests, we are open to discussion and collaboration. Reach out to us to explore potential partnerships, share ideas, or discuss mutual interests in advancing scientific knowledge and innovation.
